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Abstract
Mitral regurgitation (MR) remains the second dominant defect in the structure of valvular cardiac diseases.
It affects more than 2 million people in the USA. Basic causes are classified as degenerative (with valve prolapse) and isch-
emic (due to ischemic heart disease) in advanced countries or rheumatic ones (in developing countries).
Alone radical method of MR treatment is surgical correction through mitral valve repair (MVRe) or replacement (MVR) 
yielding definitely higher survival percentage and improvement of heart failure (HF) class comparing to pharmacotherapy.
Evolution of approaches to the management of non-ischemic MR passed through some stages starting from predominantly 
MVR to organ-preserving approaches like plastic repair.
In the prospective single-center study were analyzed the results of treatment of 72 patients with primary MR (PMR) who 
were subjected to mitral valve replacement (MVR) or plastic mitral valve repair (MVRe) performed in the Department of cardiac 
surgery affiliated with Lviv regional clinical hospital (Ukraine) since October, 2013 till February, 2016.
The conclusions of performed study are next:
1. Key direct cause of MR is the chordal rupture of MV cusps; etiological factor in the majority of advanced countries is 
degenerative changes in contrast to rheumatic changes in the developing countries.
2. Principal method of MR surgical correction in out center is MVR, though the preferable global trend is MVRe.
3. Complications and lethality percentages in this study were higher among the patients from MVR group. Improvement of 
HF class according to NYHA was more evident in the MVRe group.
This corresponds to results of other studies and guidelines that recommend MVRe as optional method for MR correction.
Keywords: primary mitral regurgitation, mitral valve replacement, mitral valve repair, tricuspid valve repair, heart failure, 
effective ejection fraction.
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1. Introduction
According to “The Euro Heart Survey on Valvular Heart Disease”, published in 2003, mitral 
regurgitation (MR) is the second frequent valvular defect after aortic valve stenosis [1].
The majority of MR causes in advanced countries are degenerative valvular changes and 
ischemic MR in contrast to developing countries, where rheumatic causes are dominant [2, 3]. 
Drug therapy as single method leads to 3 % and over 6 % of annual mortality for patients 
with moderate and severe MR accordantly [2].
There is only one radical method of MR treatment – surgical correction. It may be mitral 
valve replacement (MVR) with prosthesis valve, or mitral valve repair (MVRe). Surgery improves 
patients surviving percentage and heart failure (HF) class unlike drug therapy [4].
Plastic repair of MV is preferable to MVR in modern valve surgery era [5, 6], because of 
lower operative mortality comparing to MVR [7], no need of anticoagulation therapy after short 
“post-surgery” time [8], lower infective complications incidence associated with valve surgery [9].
2. Aim of the research
Aim of this study is prospective assessment of the features or discrepancies referring to the 
results of surgical management of the patients with primary mitral regurgitation (MR).
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3. Materials and methods
In the prospective single-center study are the results of treatment among 72 patients with 
primary MR, who were subjected to MVR or plastic repair in the Department of cardiac surgery 
affiliated with Lviv regional clinical hospital since October, 2013 till February, 2016. 
Registration of all parameters was performed 3 times (pre-op, early post-op period and in 
3 months after the operation) using special patient’s visit registration form.
The stages of MR and TR were defined – mild, moderate and severe ones. Therefore, have 
been determined a ratio between regurgitation jet area and area of left atrium, vena contract index 
and PISA method.
Echocardiography was performed before the operation, in 5–7 days and in 3 months after 
the  operation.  Echocardiograph  Sonos  5500  (Phillips)  was  used  with multifrequency  cardiac 
probe (1-2.5 MHz).
Besides ejection fraction (EF) was also provided measurement using Simpson method and 
Teicholz method  so-called  “effective”  (Doppler-derived) EF of LV. The  essence of  this method 
is based upon the fact that LV stroke volume (SV) is determined with Doppler method and LV 




tributions were not normal (according to Shapiro-Wilk’ W test), they were described with median 
(lower-upper quartiles). Between-group differences were evaluated using Mann-Whitney U test 
for continuous and ranged variables or Fisher’s exact test for categorical variables. For qualitative 
parameters’ (frequency tables) comparison χ2-test was used. Difference between parameters was 
significant when р<0.05.
4. Results
Males prevailed in the MVRe group – 12 persons (66.67 %), female prevailed in the MVR 
group – 29 persons (53.7 %). Age median (minimum-maximum) was 58 years (19–79 years). 
The most common etiological factor of MR was MV degenerative changes – 41 patients 
(56.9 %). The most often direct cause of MR was chordal rupture – 43 cases (59.7 %) (Table 1).
In all patients surgical access was performed through median sternotomy. After the full 
heparinization heart-lung machine was connected through cannulation of ascending aorta and 
both vena cava separately. Moderate hypothermia (28 ºС) and cold potassium-blood cardiople-
gy were used. Applied approaches to the MV were trans-septal one and through the left atrium. 
Plastic repair of MV was done in 18 patients (25 %), MVR was performed in 54 pa-
tients (75 %).
In the MVRe group before the operation among all patients moderate MR was revealed – 
19 persons (100 %).
In the MVR group before the operation moderate MR also was revealed – 54 pa-
tients (100 %).
On the 1st and 2nd control post-op examinations in the MVRe group MR was absent 
among 16 patients (88.89 %), only 2 patients (11.11 %) had mild MR.
On the 1st and 2nd control post-op examinations in the MVR group MR was absent 
among all 51 patients (100 %).
In the MVR group predominantly two cusps were affected – 20 patients (35 %), in the 






and Ethibond have been used. Types of MV plastic correction are presented in the Table 2.
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Etiological factor of MR 72 (100)
degenerative changes in MV 41 (56.9)
chordal rupture in visually unchanged cusps 11 (15.3)
infective endocarditis 15 (20.8)
rheumatic changes in MV 4 (5.6)
isolated prolapse of cusps 1 (1.4)
Direct cause of MR 72 (113.8)
chordal rupture 43 (59.7)
prolapse of cusps 7 (9.7)
vegetations 12 (16.7)
leaflet perforation 5 (6.9)
diffuse changes 15 (20.8)
Combination of two causes 10
Table 2
Types of MV plastic corrections (in some cases combination of several types was simultaneously performed)
Type of plastic Number of patients
Linear suturing of comissura 1
Wedge resection 7
Repair with usage of only annuloplasty ring 1
MV repair using Alfieri stitch 1
Neochords’ implantation 3
Segment’s plication without resection in case of segmental prolaps 2
Linear suturing of the defect without annuloplasty ring 1
Sectoral resection (not specified in the protocol) 3
Among 4 patients performed MVRe did not yield satisfactory result during Hydraulic test, 
so they immediately were subjected to MVR. During the statistical analysis these patients were 
included into MVR group.
Among  the MV prostheses most often ones produced by “St.  Jude” – 36 cases  (70.6 %), 
“ATS” – 8 patients (15.7 %), and other companies (“Medtronic”, “Carbomedics”, “Bjork”) – 7 pa-
tients have been used. In 1 patient bioprosthesis St. Jude Epic (29 mm) was implanted. 
Sizes of  the used prostheses were 33 mm (n=1  (1.85 %)); 31 mm (n=1  (1.85 %)); 29 mm 
(n=20 (38.89)); 27 mm (n=19 (38.89 %)); 26 mm (n=2 (3.70)); 25 mm (n=8 (14.81 %)).
De Vega tricuspid valve repair was performed among 60 patients (83.3 %) (1 patient re-
quired additional suturing of TV cusp), among 12 patients (16.7 %) this approach was not used.
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Among pre-op patients subjected to MVR HF class 2 was dominant – 10 patients (55.56 %).
After the intervention on the 1st control examination in MVR group 9 patients (50 %) had 
HF class 1 and 2. 
On the 2nd control examination dominated patients with HF class 1 – 14 persons (77.78 %), 
2 patients (11.11 %) had HF class 2 and 2 patients (11.11 %) had HF class 0 according to NYHA.
Among pre-op patients from MVR group dominated HF class 3 – 38 persons (70.37 %).
After the operation on the 1st control examination among the patients subjected to MVR 
dominated persons with HF class 2 – 40 patients (74.07 %); also 9 patients (16.67 %) had HF class 3 
and 5 patients (9.26 %) had HF class 1.
After the operation on the 2nd control examination in this group of patients 29 persons 
(56.86 %) had HF class 2, 2 persons (3.92 %) had HF class 3 and 20 persons (39.22 %) had HF 
class 1 (Table 3).
Table 3
Functional class according to NYHA
Index Pre-op (%) 1
st post-op  
examination (%)
2nd post-op  
examination (%) р1-2 р2-3 Р1-3
NYHA 0 0 0 2 (2.9)
<0.001 <0.001 <0.001
1 2 (2.8) 14 (19.4) 34 (49.3)
2 21 (29.2) 49 (68.1) 31 (44.9)
3 43 (59.7) 9 (12.5) 2 (2.9)
4 6 (8.3) 0 0
In total 72 72 69
Positive trend referring to restoration of normal cardiac rhythm after the surgical interven-
tion was observed only among the patients subjected to MVRe: 14 pre-op persons (77.78 %) and 
16 persons (88.89 %) on the 1st and 2nd pos-op examination had sinus rhythm.
Negative trend referring to restoration of normal cardiac rhythm after the surgical inter-
vention was observed in the group of patients exposed to MVR: 32 pre-op patients (59.26 %), 
31 patients (57.42 %) on the 1st post op examination and 29 patients (56.86 %) on the 2nd post-op 
one had sinus rhythm.
Absolute majority of pre-op patients had left ventricular dilatation (LVD), increase of LV 
and RV end-diastolic volume (EDV) and significant increase of pulmonary artery (PA) systolic 




EF measured with Simpson method and Teicholz method has decreased in the early post-
op period and  subsequently did not  significantly  change;  some  increase of EF measured with 
Simpson method on the 3rd examination comparing to the 2nd one have been noted. In contrast, 
the pre-op effective (Doppler-derived) EF was significantly decreased comparing to normal pa-
rameters, clearly has increased in the early post-op period and has been reliably increasing up to 
the 3rd examination (Table 4).
In the MVR group one complication (acute dynamic ileus) occurred, that required laparoto-
my and small intestine’s decompression.
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Pre-op  and  post-op  echocardiographic  indices,  median  (min.-max.),  quartiles  [upper-lower];  ESV  –  end-
systolic volume of LV, EF – ejection fraction
Parameter Pre-op 1
st post-op  
examination
2nd post-op  
examination р1-2 р2-3 Р1-3
EDV 5.35 (4.3–6.9) 4.65 (3.8–6.6) 4.6 (3.8–6.3) <0.0001 0.31 <0.0001
ESV 3.25 (2.4–4.9) [3.1–3.7]
3.25 (2.2–5) 
[2.8–3.8] 3.1 (2.1–4.8) 0,56 0.25 0.16
LA 5.1 (4–8.,8) [4.7–5.55] 4.6 (3–8.2) [4.2–4.9] 4.4 (3.4–7.7) [4.1–4.9] <0.0001 0.038 <0.0001
LV 3 (2.1–3.9) [2.8–3.1] 2. 8 (1.8–3.8) [2.6–3] 2.6 (2–3.6) [2.4–2.9] <0.0001 0.01 <0.0001
PA systolic pressure  57 (0–105) [47.5–66.5] 38 (0–70) [30.5–44] 34 (0–70) [29–39] <0.0001 <0.0001 <0.0001
EF (Teicholz method) 68 (50–82) [63.5–71] 58 (30–76) [47–65] 57 (24–77) [52–61] <0.0001 0.97 <0.0001
EF (Simpson method) 69 (50–72) [68–71] 58 (23–68) [53–61] 60 (26–66) [58–62] <0.0001 0.016 <0.0001
Effective EF 36 (17–77) [30–41] 58 (23–87) [50–69] 64 (26–84) [57–75] <0.0001 0.009 <0.0001
In the MVR next complications were observed: pericardial drainage (1 patient); two succes-
sive pericardial drainages (1 patient); auxiliary artery embolism with subsequent thrombectomy 
(1 patient); acute ischemic stroke (1 patient).
In the MVR group after the operation 3 persons died: one female patient died on the 60th day 
after the surgery (infectious endocarditis with embologenic vegetations of the MV posterolateral 
cusp and abscess of the LV posterior wall) due to polyorganic (in particular, renal) insufficiency; 
one male patient (pre-op infectious endocarditis with vegetations and perforation of MV antero-
medial cusp); one male patient died due to sudden cardiac arrest with subsequent failed cardiopul-
monary resuscitation.
In the group of patients subjected to MVRe due to primary MR during in-patient depart-
ment stay and next two control visits no lethal cases were revealed.
5. Discussion
MVRe in compare to MVR yields better results and among patients with severe organic 
MR diminished mortality down to 70 %. The best short-term and long-term results are registered 
in non-symptomatic patients operated in big referential centers with low surgical mortality (less 
than 1 %) and high percentage of repairs (over 80-90 %). These results stress the importance of 
early detection, assessment and management of MR [2]. MVR or MVRe must be done in a timely 
fashion before the onset of symptoms, ventricular dysfunction or atrial fibrillation [5], to achive 
best results. Especially atrial fibrillation is negative precursor for higher mortality rates, risk of 
stroke and left ventricular dysfunction in patients with MR [10]. 
MVRe has also benefits because of no need of long aggressive anticoagulation therapy [11].
Long-term studies showed that comparing to medical treatment early surgical intervention 
on MV among patients with prolapse of cusps was associated with significantly lower risk of the 
future death due to cardiac causes or HF and longer life expectancy [4]. Also bleeding risk in older 
patients is lower when MVR performed [12].
Echocardiographic methods of MR severity assessment give a chance to reveal promptly 
disease’s progression before the appearance of the evident or new symptoms. In turn, it allows 
to specify the timely indications for surgical intervention during repeated examinations aimed at 
regurgitation’s stage assessment [13, 14].
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In the study conducted by James et al. [15] it was proved, that during 8 years among 
58370 patients subjected to isolated primary operations on MV due to MR (n=47.126) prevalence 
of MVRe comparing to MVR increased from 51 % to 69 % (p<0.0001). Among the patients from 






paring to MVR (2–4 % versus 5–10 %). Among the patients with MV prolapse remote clinical 
outcomes were wonderful, survival rate was 80 and 94 % during the next 5 and 10 years in MVRe 
group comparing to 40 and 60 % in MVR group. There trends correspond to the results of this 
study, characterized by lower mortality in MVRe group.
Gillinov et al. [3] noted, that in 10 years after the MVRe reoperation absence rate was 93 %. 
Among 30 patients, who required reoperations due to late valvular dysfunction, repair was unsuc-
cessful in 16 persons (53 %) owing to progressive degenerative disease. Firmness/stability of the 
repair yielded negative result among the patients with preceding prolapse of posterolateral cusp, 
ones subjected to chordal shortening, independent annuloplasty, and resection of posterolateral 
cusp without annuloplasty. Results of the plastic correction were steadier in the patients with iso-
lated prolapse of posterolateral cusp, exposed to resection of posterolateral cusp and annuloplasty. 
Independent (as the single method) chordal shortening, annuloplasty and resection of cusps without 
annuloplasty jeopardized positive remote results of surgical management.
Interestingly, according to some studies [16] surgical intervention was denied for 49 % pa-
tients with severe symptomatic MR. Diminution of LV EF, old age, co-morbid conditions were the 
basic striking features of the patients who were denied. Importance of age and LV EF referring to 
patients’ operability are still discussible. 
Negative dynamics concerning restoration of sinus rhythm among the patients subjected to 
MVR probably may be explained by more severe preceding pre-op state, more prolonged medical 
history  and  consequently  larger  size  of LA and prolonged medical  history  of  atrial  fibrillation. 
These factors are known negative predictors of preservation and restoration of sinus rhythm af-
ter the surgical correction of MR. Along with MV correction these patients were not exposed to 
simultaneous open-surgery isolation of pulmonary veins, ablation of caval-tricuspid isthmus and 
areas of possible arrhythmias expansion on the basis of MV [17]. Open ablation in atrial fibrillation 
improves post op outcome referring preservation of sinus rhythm and non-recurrence period’s du-
ration [18]. This procedure is feasible and safe [19, 20] in modern surgery era.
6. Conclusions
1. Key direct cause of MR is the chordal rupture of MV cusps; etiological factor in the 
majority of advanced countries is degenerative changes in contrast to rheumatic changes in the 
developing countries.
2. Principal method of MR surgical correction in out center is MVR, though the preferable 
global trend is MVRe.
3. Complications and lethality percentages in this study were higher among the patients 
from MVR group. Improvement of HF class according to NYHA was more evident in the 
MVRe group.
This corresponds to results of other studies and guidelines that recommend MVRe as op-
tional method for MR correction.
References
[1] Iung, B. (2003). A prospective survey of patients with valvular heart disease in Europe: The 








[2] Enriquez-Sarano, M., Akins, C. W., Vahanian, A. (2009). Mitral regurgitation. The Lancet, 
373 (9672), 1382–1394. doi: 10.1016/s0140-6736(09)60692-9
[3] Gillinov, A. M., Cosgrove, D. M., Blackstone, E. H., Diaz, R., Arnold, J. H., Lytle, B. W. et. al. 
(1998). Durability of mitral valve repair for degenerative disease. The Journal of Thoracic and Cardiovascular 
Surgery, 116 (5), 734–743. doi: 10.1016/s0022-5223(98)00450-4
[4] Ling, L. H., Enriquez-Sarano, M., Seward, J. B., Orszulak, T. A., Schaff, H. V., Bailey, K. R. 
et. al. (1997). Early Surgery in Patients With Mitral Regurgitation Due to Flail Leaflets : A Long-term Out-
come Study. Circulation, 96 (6), 1819–1825. doi: 10.1161/01.cir.96.6.1819
[5] Adams, D. H., Rosenhek, R., Falk, V. (2010). Degenerative mitral valve regurgitation: best prac-
tice revolution. European Heart Journal, 31 (16), 1958–1966. doi: 10.1093/eurheartj/ehq222
[6] Otto, C. M. (2001). Evaluation and Management of Chronic Mitral Regurgitation. New England 
Journal of Medicine, 345 (10), 740–746. doi: 10.1056/nejmcp003331
[7] Enriquez-Sarano, M., Basmadjian, A.-J., Rossi, A., Bailey, K. R., Seward, J. B., Tajik, A. J. 
(1999). Progression of mitral regurgitation. Journal of the American College of Cardiology, 34 (4), 1137–1144. 
doi: 10.1016/s0735-1097(99)00313-7
[8] Gammie,  J.  S.,  Sheng,  S.,  Griffith,  B.  P.,  Peterson,  E.  D.,  Rankin,  J.  S.,  O’Brien,  S.  M., 
Brown, J. M. (2009). Trends in Mitral Valve Surgery in the United States: Results From The Society of Tho-
racic Surgeons Adult Cardiac Database. The Annals of Thoracic Surgery, 87 (5), 1431–1439. doi: 10.1016/ 
j.athoracsur.2009.01.064
[9] Mirabel, M., Iung, B., Baron, G., Messika-Zeitoun, D., Detaint, D., Vanoverschelde, J.-L. et. at. 
(2007). What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied 
surgery? European Heart Journal, 28 (11), 1358–1365. doi: 10.1093/eurheartj/ehm001




(2008). Guideline on antiplatelet and anticoagulation management in cardiac surgery. European Journal of 
Cardio-Thoracic Surgery, 34 (1), 73–92. doi: 10.1016/j.ejcts.2008.02.024
[12] Fedoruk, L. M., Jamieson, W. R. E., Ling, H., MacNab, J. S., Germann, E., Karim, S. S., Lichten-
stein,  S. V.  (2009).  Predictors  of  recurrence  and  reoperation  for  prosthetic  valve  endocarditis  after  valve 
replacement surgery for native valve endocarditis. The Journal of Thoracic and Cardiovascular Surgery, 
137 (2), 326–333. doi: 10.1016/j.jtcvs.2008.08.024
[13] Kang, D.-H., Kim, J. H., Rim, J. H., Kim, M.-J., Yun, S.-C., Song, J.-M. et. al. (2009). Compar-
ison of Early Surgery Versus Conventional Treatment in Asymptomatic Severe Mitral Regurgitation. Circu-
lation, 119 (6), 797–804. doi: 10.1161/circulationaha.108.802314
[14] Gammie,  J.  S.,  Sheng,  S.,  Griffith,  B.  P.,  Peterson,  E.  D.,  Rankin,  J.  S.,  O’Brien,  S.  M., 
Brown, J. M. (2009). Trends in Mitral Valve Surgery in the United States: Results From The Society of Tho-
racic Surgeons Adult Cardiac Database. The Annals of Thoracic Surgery, 87 (5), 1431–1439. doi: 10.1016/ 
j.athoracsur.2009.01.064
[15] O’Gara, P., Sugeng, L., Lang, R., Sarano, M., Hung, J., Raman, S. et. al. (2008). The Role of 
Imaging in Chronic Degenerative Mitral Regurgitation. JACC: Cardiovascular Imaging, 1 (2), 221–237. 
doi: 10.1016/j.jcmg.2008.01.011
[16] Shuhaiber, J., Anderson, R. J. (2007). Meta-analysis of clinical outcomes following surgical mi-
tral valve repair or replacement. European Journal of Cardio-Thoracic Surgery, 31 (2), 267–275. doi: 10.1016/ 
j.ejcts.2006.11.014
[17] Gillinov, A. M., Blackstone, E. H., Nowicki, E. R., Slisatkorn, W., Al-Dossari, G., John-
ston, D. R. at. al. (2008). Valve repair versus valve replacement for degenerative mitral valve disease. The 
Journal of Thoracic and Cardiovascular Surgery, 135 (4), 885–893. doi: 10.1016/j.jtcvs.2007.11.039
Original Research Article:
full paper













8 (4), 553–572. doi: 10.2174/157016110791330807
